Cipla Limited
CIPLA · NSE · Pharmaceuticals & Healthcare
Tentang perusahaan
Cipla is among India's oldest and most respected pharmaceutical companies, known for making HIV/AIDS medicines accessible globally in the early 2000s. It manufactures branded and generic medicines across respiratory, anti-infectives, cardiovascular, and urology segments. Cipla exports to over 100 countries and is expanding in the US specialty and biosimilar markets.
| Bursa | NSE |
| Kode saham | CIPLA |
| Sektor | Pharmaceuticals & Healthcare |
| Kapitalisasi pasar indikatif USD | $12.50B |
| Situs web | Kunjungi situs web |
Harga langsung
Memuat harga terkini…
| Kapitalisasi pasar | |
| Kisaran harian | |
| Kisaran 52 minggu |
Cara membeli
Di pasar asal (NSE), dapat diakses melalui broker global yang menawarkan bursa tersebut:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- National Stock Exchange of India — pencatatan resmi di bursa
Hanya informasi ketersediaan — bukan rekomendasi atau penawaran untuk membeli. Konfirmasikan kelayakan, biaya, dan ketersediaan terkini dengan broker Anda.
Perusahaan lain di India
Data perusahaan dan harga langsung apa pun bersifat indikatif, mungkin tertunda atau tidak akurat, dan hanya untuk riset — bukan saran investasi. Verifikasi dengan bursa, pengajuan perusahaan, dan broker Anda.